The AVITA as seen in an image from an Element Biosciences 3D demo. Photo credit: elementbiosciences.com/3d-virtual-demo
San Diego’s Element Biosciences has announced over $277 million in Series D investment to support its growing customer base with DNA sequencing and other technologies.
The oversubscribed round was led by Wellington Management with participation from new and existing investors, including Samsung Electronics, Fidelity, Foresite Capital, funds and accounts…
Read More…